Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04320979 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Chinese Academy of Medical Sciences to Cancer Institute and Hospital, Chinese Academy of Medical Sciences Primary completion date changed from estimate of May 2024 to Nov 1, 2025 · Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 2000 to confirmed 2400 · 6 morev5 Show 9 more changesShow less
    • Primary completion date changed from estimate of May 2024 to Nov 1, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 2000 to confirmed 2400
    • Completion date: May 2024 to May 2030
    • Secondary endpoints: details revised at 1 of 8 entries
    • Study description expanded, about 14 words
    • Site details revised
    • Collaborators: 24 to 21
    • Eligibility criteria expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  2. Site contact updatedv4
  3. Eligibility criteria revised Secondary endpoints revised (8)v3 Show 1 more changeShow less
    • Secondary endpoints revised (8)

    See this version in full on ClinicalTrials.gov ↗

  4. Start date changed from estimate of May 2020 to May 8, 2020v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients treated with mastectomy or breast-conserving surgery.
Trial Details
NCT Number NCT04320979
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborators: Hebei Medical University Fourth Hospital, Shanghai Zhongshan Hospital, Zhejiang Cancer Hospital, Beijing Hospital, Liaoning Cancer Hospital & Institute, Jilin Provincial Tumor Hospital, Tangshan People's Hospital, The First Hospital of Jilin University, West China Hospital, Peking Union Medical College Hospital, Henan Cancer Hospital, Zhongnan Hospital, Peking University Cancer Hospital & Institute, Fudan University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Air Force Military Medical University, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Chinese Academy of Medical Sciences, Fuwai Hospital, LanZhou University, Jiangsu Province Hospital of Traditional Chinese Medicine, Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Conditions Breast Cancer
Enrollment 2,400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov